House Vote - Monday, March 6, 2017 2:19:21 PM
HB1592 - TO PROVIDE PARITY IN HEALTH BENEFIT PLAN COVERAGE BETWEEN ORALLY ADMINISTERED ANTICANCER MEDICATION AND INTRAVENOUSLY ADMINISTERED ANTICANCER MEDICATION.
Yeas: 91
Nays: 0
Non Voting: 9
Present: 0
Excused: 0